Daratumumab for systemic AL amyloidosis: prognostic factors and adverse outcome with nephrotic-range albuminuria - Kimmich, Christoph; Terzer, Tobias; Benner, Axel; Dittrich, Tobias; Veelken, Kaya; Carpinteiro, Alexander; Hansen, Timon; Goldschmidt, Hartmut; Seckinger, Anja; Hose, Dirk; Jauch, Anna; Wörner, Stefan M.; et al. (Blood, 2020)
Gesehen am 16.09.2020